Binex is a biopharmaceutical company continuously striving to expand into various healthcare sectors, including biopharmaceuticals and synthetic pharmaceuticals. As the first CDMO (Contract Development and Manufacturing Organization) for biopharmaceuticals in Korea, the company operates GMP production facilities in Songdo, Incheon, and Osong, Chungbuk. It has also completed the construction of a new state-of-the-art GMP facility in Busan, specializing in the production of probiotics and eye drops, which meets global quality standards, providing a differentiated competitive edge.

Cell Line Development: BINEX provides cell line development service that ensure the establishment of cell lines with assured productivity, viability, monoclonality, and sterility. Through our cell line development services, it is possible to establish cell lines utilizing various expression systems (DHFR, GS, etc.) and we also performs selective cell line screening through pre-assessment of yield and quality. Process Development : BINEX has extensive process development experience for various mammalian cell and microbial projects. Leveraging our expertise and knowledge, we provide customized and optimized process development services. Furthermore, for large-scale production, we offer optimized process establishment services considering stability and cost-effectiveness. Analytical Method Development : BINEX provides analytical method development services for reliable quality assessment. Non-GMP Production : For successful technology transfer, BINEX's non-GMP production equipment is configured similarly to GMP facilities. Research material manufacturing including preclinical material production is feasible within BINEX’s non-GMP facilities. Protein structure / characterization analysis : BINEX offers a wide range of protein structure and characterization analysis services, including protein equivalence comparison. Leveraging state-of-the-art mass spectrometers, comprehensive analysis services are provided for protein structure, PTMs, glycosylation analysis, and more.

Public

Biotech, Pharma, CDMO